Synapse - Isabel Preeshagul

Results (35)

Prospective evaluation of a single-day multidisciplinary clinic for patients with locally advanced non-small cell lung cancer

Meeting Abstract

Billing, D. L.; Chaft, J. E.; Jones, D. R.; Daly, R.; Schoenfeld, A. J.; Mueller, B. A.; Preeshagul, I.; Park, B. J.; Iyengar, P.; Gomez, D. R.
Journal of Thoracic Oncology (2024)

Fulltext@MSK | Save

Exploratory analysis of ctDNA and imaging response in the phase I/II CHORUS study of canakinumab with chemoradiation and durvalumab consolidation for stage Ill NSCLC

Meeting Abstract

Shaverdian, N.; Offin, M.; Charalambous, K.; Gelblum, D.; Santini, F.; Boe, L. A.; Shepherd, A. F.; Gewanter, R. M.; Shin, J. Y.; Rimner, A.; more...
International Journal of Radiation Oncology, Biology, Physics (2024)

Fulltext@MSK | Save

A phase I/II study of valemetostat (DS-3201b), an EZH1/2 inhibitor, in combination with irinotecan in patients with recurrent small-cell lung cancer

Journal Article

Choudhury, N. J.; Lai, W. V.; Makhnin, A.; Heller, G.; Eng, J.; Li, B.; Preeshagul, I.; Santini, F. C.; Offin, M.; Ng, K.; more...
Clinical Cancer Research (2024)

Fulltext@MSK | Save

Optimizing clinical research in a regional cancer center network: A survey-based approach

Meeting Abstract

Preeshagul, I. R.; Syldor, A.; Terzulli, S. L.; Gordon, R. A.; Evans, L. A.; Moran, S.; Eng, J.; Daly, R. M.; Rao, D.; Momtaz, P.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK-positive advanced non-small cell lung cancer

Journal Article

Bauman, J. R.; Liu, G.; Preeshagul, I.; Liu, S. V.; Melosky, B.; Abrahami, D.; Li, B.; Thomaidou, D.; Duncan, K.; Krulewicz, S.; more...
Lung Cancer (2024)

Fulltext@MSK | Save

Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): An open-label, randomised, controlled, phase 2 study

Journal Article

Tsai, C. J.; Yang, J. T.; Shaverdian, N.; Patel, J.; Shepherd, A. F.; Eng, J.; Guttmann, D.; Yeh, R.; Gelblum, D. Y.; Namakydoust, A.; more...
Lancet (2024)

Fulltext@MSK | Save

Exploring published and novel pre-treatment CT and PET radiomics to stratify risk of progression among early-stage non-small cell lung cancer patients treated with stereotactic radiation

Journal Article

Thor, M.; Fitzgerald, K.; Apte, A.; Hun Oh, J.; Iyer, A.; Odiase, O.; Nadeem, S.; Yorke, E. D.; Chaft, J.; Wu, A. J.; more...
Radiotherapy and Oncology (2024)

Fulltext@MSK | Save

Clinical and genomic features of response and toxicity to sotorasib in a real-world cohort of patients with advanced KRAS G12C-mutant non-small cell lung cancer